Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age -a systematic review
- 1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States
- 2School of Medicine, Tufts University School of Medicine, Boston, MA, United States
- 3Department of Public Health and Community Medicine, Universidad de Antioquia, Medellin, Columbia
- 4Cochrane US Mentoring Program, Boston, MA, United States
- 5US Mentoring Program, Boston, MA, United States
- 6WHO Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
A Corrigendum on
By Jahanfar S, Mortazavi J, Lapidow A, Cu C, Al Abosy J, Morris K, Becerra-Mateus JC, Steinfeldt M, Maurer O, Bohang J, Andrenacci P, Badawy M, Ali M (2024). Front. Glob. Womens Health. 5:1487820. doi: 10.3389/fgwh.2024.1487820
Error in Figure/Table
In the published article, there was an error in the quality of the Figures is poor quality for 3, 4, 5, 6, 7, 8, 9, 10 as published. It is difficult to read the figures.
So I am resending figures in high quality in two formats of: PDF and PNG.
The figures are as under:
FIGURE 3 Forest plot on hormonal contraceptive methods and ovarian cancer.
FIGURE 4 Forest plot on No-hormonal contraceptive methods and ovarian cancer.
FIGURE 5 Forest plot on hormonal contraceptive Use and endomentrail (Correct spelling is endometrial) cancer.
FIGURE 6 Forest plot on hormonal contraceptive Use and cervical cancer.
FIGURE 7 Forest plot on OCP use and gynecological cancer hazard.
FIGURE 8 Forest plot on hormonal contraceptive Use and breast cancer.
FIGURE 9 Forest plot on oral contraceptive Use and ovarian cancer by mutation carries.
FIGURE 10 Forest plot on oral contraceptive Use and breast cancer by mutation carries.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: contraceptives, ovarian cancer, cervical cancer, endometrial cancer, breast cancer
Citation: Jahanfar S, Mortazavi J, Lapidow A, Cu C, Al Abosy J, Morris K, Becerra-Mateus JC, Steinfeldt M, Maurer O, Bohang J, Andrenacci P, Badawy M and Ali M (2024) Corrigendum: Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age—a systematic review. Front. Glob. Womens Health 5:1530251. doi: 10.3389/fgwh.2024.1530251
Received: 18 November 2024; Accepted: 26 November 2024;
Published: 9 December 2024.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright: © 2024 Jahanfar, Mortazavi, Lapidow, Cu, Al Abosy, Morris, Becerra-Mateus, Steinfeldt, Maurer, Bohang, Andrenacci, Badawy and Ali. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Moazzam Ali, YWxpbW9hQHdoby5pbnQ=